Home page iconHOME |   Contents page iconCONTENTS |   Search iconSEARCH |  Previous Years  PREVIOUS YEARS |
Table of contents

  You are in:

Outcome 3 – Access to Medical Services

Access to cost-effective medical, practice nursing and allied health services, including through Medicare subsidies for clinically relevant services

prev page | TOC | next page


PDF printable version of Outcome 3 – Access to Medical Services (PDF 655 KB)

Outcome Strategy

Outcome 3 aims to provide access to high quality medical, dental and associated services to help people manage their health. This access is provided through the Medicare system. The department worked to achieve this Outcome by managing initiatives under the programs outlined below.

This chapter reports on the major activities undertaken by the department during the year, reporting against each of the major activities and performance indicators published in the Outcome 3 chapter of the 2010-11 Health and Ageing Portfolio Budget Statements (PB Statements) and the 2010-11 Health and Ageing Portfolio Additional Estimates Statements (PAES). It also includes a table summarising the estimated and actual expenditure for this Outcome.

Outcome 3 was managed in 2010-11 by the Medical Benefits Division, the Acute Care Division and the Population Health Division.

Program Name Program Objectives in 2010-11
Program 3.1: Medicare Services
  • Improve access to evidence-based, best practice medical services.
  • Improve access to clinically relevant dental services.
Program 3.2: Alternate Funding for Health Service Provision
  • Support access to necessary medical services that may not be available through mainstream mechanisms or which may not be available in Australia.
Program 3.3: Diagnostic Imaging Services
  • Support access to high quality, safe, clinically relevant and cost effective diagnostic imaging services, including services performed using x-ray, computed tomography, ultrasound, magnetic resonance imaging, cardiac imaging, and nuclear medicine technologies, including positron emission tomography services.
Program 3.4: Pathology Services
  • Support access to high quality, safe, clinically relevant and cost-effective pathology services.
Program 3.5: Chronic Disease – Radiation Oncology
  • Complement the delivery of radiation oncology services under Medicare (Program 3.1) and the Regional Cancer Centres Initiative (Outcome 10) by improving access to, and quality of, appropriately staffed and equipped radiation oncology treatment facilities for Australians with cancer.
Program 3.6: Targeted Assistance – Medical
  • Provide targeted assistance to eligible people to access health care, currently not covered under existing programs, including breast prostheses reimbursements.

Major Achievements

  • A new five year Pathology Funding Agreement between the Government and the pathology sector was signed in April 2011 that ensures patients can access quality, affordable pathology services and is expected to generate savings of more than $500 million over the five years.
  • Improved access to specialist services for people in remote, regional and outer metropolitan areas and people in aged care homes and Aboriginal Medical Services by providing new rebates and incentives for specialist consultations provided by video conference.
  • Implemented new Medicare arrangements for midwives and nurse practitioners to improve choice and access to maternity care for women and their families, and to increase access to primary care services.
  • New radiation oncology facilities in Cairns (Queensland) and Orange (New South Wales) became operational in 2010-11, providing local access to cancer treatment for residents in those areas.

Challenges

  • The emergence of potential irregularities in the administration of the Professional Services Review (PSR) Scheme. The PSR Advisory Committee, comprising the department, Australian Medical Association, Professional Services Review and Medicare Australia, is now working to help the PSR improve transparency and effectiveness of PSR processes.
  • Maintaining the flow of applications to the Medical Services Advisory Committee while trialling new processes and documentation for submission based applications and agreed decision analytic protocols. This has been managed, in part, through the introduction of transition arrangements for applications for co-dependent technologies that require advice from more than one advisory committee.
  • Delayed closure of the Medicare Chronic Disease Dental Scheme.

Top of page

Program 3.1: Medicare Services

Program 3.1 aims to improve access to evidence-based, best practice medical services. It also aims to improve access to clinically relevant dental services.

Improve Access to Evidence-Based Medical Services

During 2010-11 the department commissioned an independent review of the impact of capping Extended Medicare Safety Net benefits (EMSN). Capping of some EMSN benefits was introduced on 1 January 2010 following decision taken in the 2009-10 Budget. The independent review of capping has been tabled in Parliament and provides valuable information to guide further reform of the EMSN arrangements.

The department developed the policy and regulatory framework to support the Government’s 2010 election commitment, ‘Connecting Health Services with the Future: Modernising Medicare by Providing Rebates for Online Consultations’. This program funds video conference consultations with specialists for people in remote, regional and outer metropolitan areas of Australia. Video consultations with specialists are also funded for all care recipients in a residential care service and patients of an Aboriginal Medical Service or Aboriginal Community Controlled Health Service anywhere in Australia.

The department implemented the More Choice For Women – Expanding Medicare Support For Midwives Measure, which provides for Medicare rebateable services for midwifery care provided by appropriately qualified and experienced privately practising midwives working in collaborative arrangements with medical practitioners. The measure recognises that women should have a range of birthing options available to them and be supported in their choice of practitioner and their preference for continuity of care. Recognising midwives as primary maternity care providers under Medicare also assists in improving service delivery by enabling better use of the existing workforce and the development over time of new, more innovative models of care that can be tailored to meet local needs.

The department also implemented the Expansion of the Nurse Practitioner Workforce Measure, which allows eligible nurse practitioners working in collaborative arrangements with medical practitioners, to provide Medicare rebateable services within their scope of practice. This measure was designed to assist in improving the flexibility and capacity of the primary care health workforce. Both measures were implemented on 1 November 2010 following extensive stakeholder consultation through advisory and technical advisory groups. Eligible midwives and nurse practitioners can also request a range of diagnostic tests, refer patients to specialists and consultant physicians and prescribe certain medicines under the Pharmaceutical Benefits Scheme (PBS) within their scope of practice.

The department worked with the independent Professional Services Review (PSR) agency, Medicare Australia and other key stakeholders, including the Australian Medical Association, to improve arrangements supporting the integrity of the Medicare program, by making PSR processes more transparent and effective.

The role of the Medical Services Advisory Committee (MSAC) was expanded to provide evidence-based advice to Government on all changes to and reviews of the Medicare Benefits Schedule. This will allow new items, amendments of existing items or reviews of major components of the Schedule to be undertaken with consistency in approach to allow independent expert advice on the best health outcomes for Australians. This activity is important in that it will deliver evidence-based advice on all aspects of public reimbursement through processes that allow greater community input.
Qualitative Deliverable:Develop an MBS Quality Framework.
2010-11 Reference Point:Timely consultation with stakeholders, including health consumers, and the establishment of three committees to inform the advice provided to Government.
Result: Deliverable substantially met.
The development of the MBS Quality Framework involved three key elements:
  • introduction of a new evaluation and listing process for MBS items that utilise the Medical Services Advisory Committee for all items;
  • strengthening arrangements for appropriately pricing and listing new MBS services; and
  • establishing systematic MBS monitoring and review processes to inform appropriate
    amendment or removal of existing MBS items.
The previous assessment of proposed new MBS items was formalised by developing a consistent and transparent process to determine eligibility for MBS listing informed by independent expert advice. To promote consistency of expert advice to Government on issues affecting the MBS, advice on outcomes from the work undertaken through the MBS Quality Framework is provided by the Medical Services Advisory Committee rather than listing MBS items assessed through the MBS Quality Framework on an interim basis as initially envisaged.
Over the past two years the department has consulted widely with stakeholders through a large number of bilateral meetings with peak stakeholder organisations, as well as through public input to discussion papers and focus groups and in trials of new listing and review processes for MBS items in relation to the MBS Quality Framework. The department will continue to seek advice from these stakeholders as implementation of the Comprehensive Management Framework for the MBS progresses.
Qualitative Deliverable:Evaluation plans developed for new MBS items that are not assessed by the Medical Services Advisory Committee.
2010-11 Reference Point:All new MBS items have an evaluation plan developed in consultation with relevant stakeholders prior to listing on the MBS.
Result: Deliverable met.
An evaluation framework for new items was developed as part of the MBS Quality Framework. The department developed a new evidence-based approach to the assessment of services not previously evaluated by the Medical Services Advisory Committee (MSAC). Design and testing of the framework resulted in recognition that the approach would be best implemented through expansion of the role of MSAC. The Comprehensive Management Framework for the Medicare Benefits Schedule (MBS) was announced by the Government in the 2011-12 Budget and has subsumed the former MBS Quality Framework. The department will report back to the Government on progress under the Comprehensive Management Framework for the MBS in time to inform funding decisions as part of the 2013-14 Budget.

Qualitative Deliverable:Results of completed health technology assessments are considered by the Medical Services Advisory Committee to provide advice to the Minister to support evidence-based decision-making.
2010-11 Reference Point:Results of health technology assessments are relevant and appropriate, and are provided to the Medical Services Advisory Committee in a timely manner.
Result: Deliverable substantially met.
In 2010-11, the department established new committee arrangements to apply from 1 January 2011 to facilitate the delivery of health technology assessments under expanded terms of reference for the Medical Services Advisory Committee. These arrangements included the establishment of a Protocol Advisory Subcommittee, an Evaluation Subcommittee and a Medical Services Advisory Committee Expert Standing Panel. The introduction of a standing panel of experts available to assist with development of protocols will reduce the time previously taken to recruit experts to Advisory Panels.
Introduction of increased applicant, stakeholder and consumer input requirements into the Protocol Advisory Committee has impacted slightly on the timeliness of commencement of assessment reports. The new process will however deliver a more widely consulted protocol and a greater degree of certainty prior to commencement of assessment reports and allow more active community engagement.
Qualitative KPI:Advice is provided to Government on a strategic, evidence-based framework for managing the MBS into the future.
2010-11 Reference Point:Advice available for consideration in the 2011‑12 Budget.
Result: Indicator met.
In 2010-11 advice was provided to Government based on the outcomes of the MBS Quality Framework initiative and recent reforms to the Medical Services Advisory Committee. In the 2011-12 Budget a further two years of funding to implement a Comprehensive Framework for Managing the MBS was introduced.

This framework builds on the work of the MBS Quality Framework and will provide the public, the health technology industry and health care professionals with a clear pathway for applying for new services to be listed on the MBS or to have existing items reviewed. There will be improved transparency and consistency in obtaining expert advice on the public funding of professional services and improved coordination.
Quantitative KPI:Number of services delivered through Medicare by providing rebates for items listed on the MBS.
2010-11 Target:334m2010-11 Actual:319m
Result: Deliverable substantially met.
Medicare rebates were provided for 319 million services, representing 14.3 services per capita.
Qualitative Deliverable:Methodologies for reviewing MBS items are developed and trialled.
2010-11 Reference Point:Stakeholders collaborate in reviews spanning various aspects of the MBS, such as single items, groups of items and clinical pathways.
Result: Deliverable met.
The department established four demonstration reviews – surgical interventions for the treatment of obesity; pulmonary artery catheterisation; colonoscopy; and a whole of specialty review of ophthalmology – in order to develop and trial methods of reviewing MBS items. The reviews were supported by external consultants experienced in health service evaluation who took a mixed-methods approach to evidence including fit-for-purpose health technology assessments, concordance with clinical practice guidelines, data analysis, and consumer engagement.

Each review was undertaken in an open and cohesive way with relevant stakeholders such as the medical craft groups and the Consumers Health Forum. Additionally, reviews were informed by clinical expert advice through Clinical Working Groups.

Under new arrangements introduced from 1 January 2011 the Medical Services Advisory Committee will provide advice to Government on the outcomes of these reviews.

Qualitative Deliverable:Develop a cohesive, strategic health technology assessments framework.
2010-11 Reference Point:Commonwealth health technology assessments processes progressively aligned within the strategic policy framework proposed by the Review of Health Technology Assessment in Australia (December 2009).
Result: Deliverable substantially met.
The department is implementing recommendations from the Review of Health Technology Assessment in Australia within the recommended strategic policy framework in a phased approach. This is intended to reduce the impact on ‘business as usual’ (as some recommendations are reliant on the completion of others) and to permit ongoing refinement as the other recommendations are addressed.

Deliverables due in 2010 were delivered on time and substantial progress has been made towards ensuring recommendations due in 2011, which relate to improving procedural fairness and transparency and providing for greater consistency across Commonwealth health technology assessment processes, will meet forecast timeframes. The review of Health Technology Assessment Review implementation activity which is due in 2013 will further assist in guiding any necessary alignment.
Top of page

Improve Access to Clinically Relevant Dental Services

In 2010-11, the department continued to improve access to dental services by working with Medicare Australia to ensure access to preventative dental services for teenagers aged 12-17 years old, under the Medicare Teen Dental Plan.
A challenge for the department this year was the continuing delayed closure of the Medicare Chronic Disease Dental Scheme. The Government attempted to close the Scheme in 2008 but the necessary legislative instrument was disallowed by the Senate. The closure was to make funding available for the introduction of a new Commonwealth Dental Health Program (discussed in Outcome 13 – Acute Care). It remains Government policy to close the Scheme.

As announced in the 2011-12 Budget, the department will work to establish a National Advisory Council on Dental Health to provide advice to the Minister for Health and Ageing on options to address identified priority areas for dental health (discussed in Outcome 13 – Acute Care).

Quantitative Deliverable:Number of vouchers provided to eligible teenagers.
2010-11 Target:1.3m2010-11 Actual:1.2m
Result: Deliverable substantially met.
In 2010-11, 1,226,534 vouchers were provided to teenagers eligible for the Medicare Teen Dental Plan. A reduction in vouchers sent reflects a reduction in the number of eligible teenagers over the period.
Quantitative KPI:Percentage uptake of preventative dental checks by eligible teenagers.
2010-11 Target:33%2010-11 Actual:30%
Result: Indicator substantially met.
The Medicare Teen Dental Plan is a demand driven, calendar year program. As eligibility for benefits
spans the full calendar year, vouchers issued in 2010 and 2011 can be used for services outside of the 2010-11 reporting period. Claims for benefits may also be made for several years after the date of service.
Top of page

Whole of Program Performance Information

Qualitative Deliverable:Produce relevant and timely evidence-based policy research.
2010-11 Reference Point:Relevant evidence-based policy research produced in a timely manner.
Result: Deliverable met.
A review of EMSN capping was undertaken by the Centre for Health Economics Research and Evaluation using Medicare claims data provided by the department and has been tabled in Parliament.
Qualitative Deliverable:Stakeholders participate in program development through a range of avenues.
2010-11 Reference Point:Stakeholders participated in program development through avenues such as regular consultative committees, conferences, stakeholder engagement forums, surveys, submissions on departmental discussion papers and meetings.
Result: Deliverable met.
The telehealth initiative was guided by consultation with the general public, through public submissions in response to a Government discussion paper and through the Telehealth Advisory Group which includes key stakeholders from peak medical, health professional, Indigenous, aged care and consumer bodies. The Telehealth Advisory Group met three times in 2010-11.

The department, in implementing new processes for Medical Services Advisory Committee assessments, has undertaken consultation with the relevant professional and industry groups as well as the community to ensure that advice provided by the Committee contributes to the improvement of long-term capacity, quality and safety of Australia’s health care system by providing expert advice on the safety, comparative clinical effectiveness and cost effectiveness of MBS items.
Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
2010-11 Target:0.5%2010-11 Actual:-0.8%
Result: Deliverable substantially met.
Actual expenditure for the MBS in 2010-11 was $16.266 billion compared with the estimated $16.392 billion. The MBS is a demand driven program that meets the medical needs of the Australian public. Factors that affect the MBS include population growth and changes in the pattern of use of medical services.

Top of page

Program 3.2: Alternative Funding for Health Service Provision

Program 3.2 aims to support access to necessary medical services that may not be available through mainstream mechanisms or which may not be available in Australia.

Medical Services Not Available Through Mainstream Mechanisms

During 2010-11, the department worked to improve access and support to necessary medical services which are not available through mainstream mechanisms such as Medicare or which are not available in Australia.

Program grants were provided to three organisations that deliver primary health care services to the homeless, the disadvantaged and the visually impaired who have difficulty accessing such services through the mainstream mechanisms. Services provided to these population groups included intervention counselling relating to addiction, lifestyle and social problems, mental health pathology, harm reduction and minimisation, self care, optometric and orthoptic consultations, scientific aids, assisted technology, and adaptive living aids for targeted individuals requiring low vision and rehabilitation assistance.

Qualitative Deliverable:Services accessible to those in need.
2010-11 Reference Point:Services delivered in accordance with program criteria and guidelines.
Result: Deliverable met.
The department administered three program grants, in accordance with the contracted schedule, to organisations that provided health services to socially disadvantaged, homeless and visually impaired people which could either not be funded through Medicare due to access barriers or could not be funded as efficiently through Medicare.
The department also provided financial assistance for necessary medical procedures performed outside Australia for 13 individuals.
Quantitative Deliverable:Number of health services provided to eligible Australian residents, that could not be provided through Medicare, due to patient access barriers.
2010-11 Target:36,4002010-11 Actual:47,856
Result: Deliverable met.
This figure was exceeded through the timely administration of relevant funding programs.
Quantitative KPI:Percentage of applications and grants processed within agreed timelines.
2010-11 Target:90%2010-11 Actual:90%
Result: Indicator met.
90% of applications and conditions of grants were processed within agreed timelines.
Qualitative Deliverable:Provision of health services through the Medical Treatment Overseas Program.
2010-11 Reference Point:Eligible Australians with life-threatening conditions are provided with support through the Program.
Result: Deliverable met.
The department provided financial support to 13 eligible Australians with life-threatening conditions for life-saving medical treatment in overseas countries.
Quantitative KPI:Percentage of applications for financial assistance under the Medical Treatment Overseas Program processed within agreed timelines.
2010-11 Target:90%2010-11 Actual:90%
Result: Indicator met.
Twenty-one applications for financial assistance under the Medical Treatment Overseas Program were processed within the minimum assessment timeframe of six weeks in accordance with the program guidelines. Timely assessment is dependent upon the availability of expert advice about the applicant’s condition and treatment options in Australia and overseas. The department efficiently administered approved financial assistance to 13 Australians including five ongoing eligible funding recipients.
Qualitative Deliverable:Regular review of gaps in service provision to ensure program objectives are met.
2010-11 Reference Point:Timely and responsive review process.
Result: Deliverable met.
The department regularly reviews reports from funding recipients to assess whether the needs of the target audience are being met through the program.

Top of page

Whole of Program Performance Information

Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
2010-11 Target:0.5%2010-11 Actual:14.6%
Result: Deliverable not met.
As this program is demand driven, approved funds are available as required to ensure that the objectives of the program are met. Whilst the dollar value of the deliverable was not met, all applications were assessed and processed in a timely manner and funding for overseas medical assistance issued as appropriate.

Program 3.3: Diagnostic Imaging Services

Program 3.3 aims to provide access to safe, efficient and clinically effective diagnostic imaging services, including services performed using x-ray, computed tomography, ultrasound, magnetic resonance imaging (MRI), cardiac imaging, and nuclear medicine technologies, including positron emission tomography (PET) services.

Safe, Cost-effective, Clinically Relevant Diagnostic Imaging Services

Review of Funding of Diagnostic Imaging Services


The Review of Funding of Diagnostic Imaging Services was initiated in the 2009-10 Budget and was completed in 2010-11 to ensure that the Government is paying the right amount in the right way to support patient access to quality diagnostic imaging services. This involved extensive consultation with diagnostic imaging stakeholders including requestors, providers, consumers, regulatory authorities and training providers. The outcomes of the Review were announced in the 2011-12 Budget with funding of $104.4 million over four years for the Diagnostic Imaging Review Reform Package, which will implement the outcomes of the review, particularly expanding patient access to magnetic resonance imaging.

Encourage more Effective use of Diagnostic Imaging Services

The department developed the framework for an inclusive and whole-of-industry focused quality program that will formalise and streamline the way in which organisations seek funding from the department to undertake diagnostic imaging quality activities. The department established the Diagnostic Imaging Quality Committee, comprised of a range of individuals with broad experience across diagnostic imaging. This committee assisted the department in determining the priority areas for diagnostic imaging quality improvement activities that could be targeted in the inaugural funding round. These priority areas are safety, appropriateness, efficiency, communication, and the consumer experience.

Qualitative Deliverable:The Australian Government will develop the framework for a comprehensive, industry-focused program for the funding of activities that improve the quality of diagnostic imaging services within Australia.
2010-11 Reference Point:The establishment of the framework by June 2011.
Result: Deliverable met.
Under the framework, a Diagnostic Imaging Quality Program was developed. The inaugural funding round was released on 22 June 2011.
Top of page

Diagnostic Imaging Accreditation Scheme

From 1 July 2010, accreditation against objective standards, developed in consultation with the professions and industry, became a condition for all practices providing Medicare eligible diagnostic imaging services.

Around 4,000 practices are now participating in the Diagnostic Imaging Accreditation Scheme. The Scheme ensures that a consistent quality of diagnostic imaging service is provided, regardless of who provides the services or where it is provided. Practices must meet a number of standards to gain accreditation. The accreditation process for individual practices is managed by one of three accreditors.

Qualitative Deliverable:Introduction of Stage II of the Diagnostic Imaging Accreditation Scheme.
2010-11 Reference Point:Stage II implemented by 1 July 2011.
Result: Deliverable met.
From 1 July 2011, radiology and non-radiology practices eligible to claim Medicare benefits are required to participate in the Scheme in order to claim Medicare benefits. Non-radiology practices have until 30 June 2011 to gain entry level accreditation which involves a practice meeting three reasonably basic standards.
Quantitative KPI:Number of practices participating in the Diagnostic Imaging Accreditation Scheme.
2010-11 Target:4,0002010-11 Actual:4,092
Result: Indicator met.
With radiology and non-radiology practices choosing to participate in the Scheme, the numbers have stabilised at 4,000 – 4,100.

Positron Emission Tomography

Positron emission tomography (PET) is a nuclear medicine imaging technology that uses a small amount of an injected radiopharmaceutical to determine the extent of diseases and conditions, such as cancer. While PET is primarily used in the staging and monitoring of malignant cancers, it can also be used in areas such as neurology.

In 2010-11, funding was provided to Austin Health in Victoria, and Westmead Hospital in New South Wales, to continue funding PET services and research. At the end of 2010-11, there were 30 PET scanners, operating out of 27 locations, providing Medicare-rebatable PET scans in Australia.
Quantitative Deliverable:Number of recommendations made or implemented by the National Prescribing Service.
2010-11 Target:22010-11 Actual:3
Result: Deliverable met.
The National Prescribing Service has delivered programs on three therapeutic topics, and initiated a project to support electronic decision support in general practice.
Qualitative KPI:Implementation of bulk-billing incentives announced in the 2009-10 Budget.
2010-11 Reference Point:Maintain or improve 2009-10 bulk-billing rates.
Result: Indicator met.
Bulk-billing rates for diagnostic imaging have continued to increase in 2010-11. This is the 7th consecutive year that bulk-billing rates for diagnostic imaging have increased.
Quantitative KPI:Increase or maintain bulk-billing rates for diagnostic imaging.
2010-11 Target:66%2010-11 Actual:73%
Result: Indicator met.
In 2010-11, the bulk-billing rates for diagnostic imaging have increased.
Top of page

Whole of Program Performance Information

Qualitative Deliverable:Produce relevant and timely evidence-based policy research.
2010-11 Reference Point:Relevant evidence-based policy research produced in a timely manner.
Result: Deliverable met.
The department has undertaken a review of the Diagnostic Imaging Quality Practice Program, which is due to report in 2011-12.
Qualitative Deliverable:Stakeholders participate in program development through a range of avenues.
2010-11 Reference Point:Stakeholders participated in program development through avenues such as regular consultative committees, conferences, stakeholder engagement forums, surveys, submissions on departmental discussion papers and meetings.
Result: Deliverable met.
The review of the Program, which included stakeholder surveys and interviews, was undertaken in 2010-11 and is due to report in 2011-12. The report will provide an analysis of the outcomes of the grant program, based on the quality initiatives implemented by practices which received a grant.
Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
2010-11 Target:0.5%2010-11 Actual:3.2%
Result: Deliverable not met.
To ensure the Government could meet its commitment to promote the provision of high quality diagnostic imaging services, additional funding was directed to projects that were in a position to build on previous quality activities in late 2010-11.
Top of page

Program 3.4: Pathology Services

Program 3.4 supports access to high quality, safe, clinically relevant and cost effective pathology services.

Review of Pathology Funding Arrangements

As a result of the Review of Pathology Funding Arrangements announced in the 2009-10 Budget, a new five-year Pathology Funding Agreement between the Government and the pathology sector was signed in April 2011. This will ensure that patients get access to quality, affordable pathology services whilst also providing better value for money for taxpayers through the generation of more than $500 million in savings over five years. This agreement was the result of extensive negotiations with the sector.

While the agreement is primarily a mechanism to manage pathology outlays, it also allows for a number of additional key components, including:

  • maintaining the Government’s competition reforms to ensure that big and small players alike
    can open new pathology collection centres;
  • a commitment to improve transparency for setting and reviewing pathology fees, including a new role for the Medical Services Advisory Committee to assess the cost-effectiveness of new pathology tests;
  • a commitment to develop a National Pathology Framework covering issues like workforce development and laboratory accreditation;
  • the integration of pathology results within eHealth records;
  • the engagement with GP stakeholder groups to investigate ways to improve support services to GPs to better request pathology services; and
  • the establishment of a working party to develop an approach for genetic services.

Access to Pathology Services

During 2010-11, the department continued to work closely with the National Pathology Accreditation Advisory Council and further refined the requirements of the National Pathology Accreditation Framework to focus on the most effective quality assurance strategies to address the areas of greatest risk to patient safety in pathology service delivery. Concerted efforts were made by the Council to align the existing pathology accreditation framework with emerging directions from the Australian Commission on Safety and Quality in Health Care where appropriate.
Quantitative Deliverable:Number of new and/or revised national accreditation standards produced for pathology laboratories.
2010-11 Target:42010-11 Actual:0
Result: Deliverable not met.
Although four new or revised standards documents were not completed in 2010-11, seven standards documents were subject to comprehensive review and are in a well-advanced state of development. Finalisation of these documents has been put temporarily on hold while the National Pathology Accreditation Advisory Council undertakes a major streamlining initiative to improve the transparency of the extensive pathology accreditation standards framework and to align it where relevant to the emerging national health care accreditation standards being developed by the Australian Commission on Safety and Quality in Health Care. Subject to the outcomes of stakeholder consultation on the proposed changes, this revision process should be completed by December 2012.

Funding from the Quality Use of Pathology Program was used to support a range of initiatives focussed on improving consumer awareness of the benefits and risks of pathology testing, providing better guidance for requesters of pathology services on the appropriate use of pathology testing, and improving the quality of service provision through support for specific quality assurance development activities in emerging fields such as genetic testing.

Qualitative Deliverable:Implementation of bulk-billing incentives announced in
2009-10 Budget.
2010-11 Reference Point:Incentives implemented by 1 November 2010.
Result: Deliverable met.
Bulk-billed pathology episode incentive items were listed on the Pathology Services Table of the Medicare Benefits Schedule effective 1 November 2010.
Qualitative Deliverable:Promote open competition through increasing patient choice of pathology provider.
2010-11 Reference Point:Removal of legislative barriers to allow patient choice.
Result: Deliverable met.
Changes to the Health Insurance Act 1973 came into effect on 11 December 2010.
Qualitative KPI:The Quality Assurance in Aboriginal and Torres Strait Islander Medical Services program continues to receive endorsement by key Indigenous stakeholder groups.
2010-11 Reference Point:Increased number of health sites enrolled in the voluntary program.
Result: Indicator met.
The number of sites increased from 133 at 30 June 2010 to 152 sites enrolled in the program at 30 June 2011.
Quantitative KPI:Number of health services supported by the Quality Assurance in Aboriginal and Torres Strait Islander Medical Services Program.
2010-11 Target:1502010-11 Actual:152
Result: Indicator met.
The department undertook consultations in 2010-11 with both Quality Assurance in Aboriginal and Torres Strait Islander Medical Service program participants and with the National Aboriginal Community Controlled Health Organisation. There was strong endorsement of the model of service provision and support provided by this program to Indigenous health services throughout Australia (including in many rural and remote communities). The number of sites enrolled in the program continued to increase over the financial year and the target number of 150 enrolled sites was exceeded.
Quantitative KPI:Percentage of Medicare-eligible laboratories meeting pathology accreditation standards.
2010-11 Target:100%2010-11 Actual:100%
Result: Indicator met.
Under the administrative arrangements set up by the department to support the effective operation of the relevant aspects of the Health Insurance Act 1973, Medicare Australia has liaised effectively with the approved accreditation assessment agency to ensure that Medicare eligibility is only available to those laboratories that meet the requirements of the national pathology accreditation standards.
Quantitative KPI:Value of bulk-billing incentive payments for pathology services.
2010-11 Target:$91.6m2010-11 Actual:$82.2m
Result: Indicator substantially met.
Although expenditure relating to the bulk-billing incentive payments was lower than estimated, a high percentage of pathology services were bulk-billed in 2010-11.
Quantitative KPI:Percentage of pathology services that are bulk‑billed.
2010-11 Target:86%2010-11 Actual:87%
Result: Indicator met.
A high bulk-billing rate for pathology services was maintained during 2010-11.
Quantitative KPI:Percentage of patients who can exercise choice between available pathology providers.
2010-11 Target:100%2010-11 Actual:100%
Result: Indicator met.
An amendment to the Health Insurance Act 1973, effective 11 December 2010, enabled patients to take their pathology request forms to the pathology provider of their choice.
Top of page

Whole of Program Performance Information

Qualitative Deliverable:Stakeholders participate in program development through a range of avenues.
2010-11 Reference Point:Stakeholders participated in program development through avenues such as regular consultative committees, conferences, stakeholder engagement forums, surveys, submissions on departmental discussion papers and meetings.
Result: Deliverable met.
The department consulted widely with professional, industry and consumer peak groups on a range of issues and through a variety of fora, including all of the above mechanisms for consultation. A strong focus on pathology workforce capacity was pursued in 2010-11, which involved a number of large meetings, consultation on report findings, and participation in meetings organised by stakeholder groups.
Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
2010-11 Target:0.5%2010-11 Actual:-10.5%
Result: Deliverable not met
The underspend represents a minor delay in the commencement of some Quality Use of Pathology Program projects due to the negotiations leading up to the finalisation of the Pathology Funding Agreement (PFA) and the need to ensure project objectives were in line with priorities agreed in the PFA.
Top of page

Program 3.5: Chronic Disease – Radiation Oncology

Program 3.5 aims to complement the delivery of radiation oncology services under Medicare (Program 3.1) and the Regional Cancer Centres Initiative (Outcome 10) by improving access to, and quality of, appropriately staffed and equipped radiation oncology treatment facilities for Australians with cancer.

Access to Radiation Oncology Services

Radiotherapy is one of the key treatments for people with cancer. Cancer is more prevalent in older people, and an increased capacity for cancer services is required as the population ages. The equipment and infrastructure associated with radiation oncology services are expensive, and there is a shortage of trained health care professionals needed to operate this highly specialised equipment.

During 2010-11, the department provided funding towards the establishment of new and expanded radiation oncology facilities in: New South Wales (Orange, which commenced treating patients in May 2011); Queensland (Cairns, which commenced treating patients in June 2011); and Tasmania (Launceston, where expanded services became operational in May 2011). These new or expanded facilities will improve access to radiation oncology services for cancer patients in these areas and surrounding regions.

Quantitative KPI:The number of sites delivering radiation oncology.
2010-11 Target:612010-11 Actual:61
Result: Indicator met.
By the end of 2010-11, 61 sites were delivering radiation oncology services. New facilities commenced operations in New South Wales, Queensland and Tasmania. The target indicator has consistently been increasing and met for the number of sites over the past three years delivering radiation oncology.

The department continued to support access to radiation oncology services through the Radiation Oncology Health Program Grants Scheme. The Scheme funds high cost equipment used in radiation oncology treatment with 61 radiation oncology facilities receiving funding under this Scheme in 2010-11. The department also continued to fund workforce related activities, including training places for radiation therapists and radiation oncology medical physicists.

Quantitative Deliverable:Number of approved radiation oncology medical physics intern positions funded.
2010-11 Target:252010-11 Actual:15
Result: Deliverable not met.
In 2010-11, 15 radiation oncology medical physics registrars commenced their first year of training. Registrars require clinical preceptor support (qualified tutors) throughout their training. Limited numbers of available clinical preceptors resulted in facilities unable to recruit to projected positions.
Quantitative Deliverable:Number of approved radiation therapy training positions.
2010-11 Target:362010-11 Actual:29
Result: Deliverable substantially met.
In 2010-11, there were 29 radiation therapy training positions in place. Facilities were unable to successfully recruit to projected positions. Ongoing liaison will be undertaken with the sector regarding recruitment strategies.

In 2010-11, the department continued to work with the sector to develop and implement a quality framework for radiation oncology, including the finalisation of a suite of radiation oncology practice standards. The focus in 2011-12 will be on options for the longer term assessment of the standards.

Qualitative Deliverable:Continued development of a framework to improve patient safety and clinical outcomes during radiation treatment.
2010-11 Reference Point:Framework developed and implemented in a timely manner.
Result: Deliverable substantially met.
On behalf of the Australian Government and state and territory governments, the department is funding the Australian Radiation Protection and Nuclear Safety Agency for three years to operate the Australian Clinical Dosimetry Service (ACDS). The ACDS commenced auditing radiation oncology facilities in January 2011. An independent evaluation will be conducted in 2013 to determine future arrangements.

The department assisted the Tripartite Committee, comprising the Royal Australian and New Zealand College of Radiologists (RANZCR), the Australian Institute of Radiography (AIR) and the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) to finalise a suite of radiation oncology practice standards.
Qualitative Deliverable:Complete a trial of the draft radiation oncology standards, to be used as part of a quality framework for the sector.
2010-11 Reference Point:Trial of standards, including advice and input from the profession, completed September 2010. Proposals for ongoing arrangements to be developed by June 2011.
Result: Deliverable substantially met.
A report on the trial of the radiation oncology practice standards, funded by the department, was finalised in May 2011. The outcomes of the trial informed the finalisation of the standards in June 2011. The trial demonstrated that the standards are usable and a practical guide to good clinical practice. The department is funding the Tripartite Committee to publish and disseminate the standards to radiation oncology facilities.

The department worked with the Radiation Oncology Reform Implementation Committee (RORIC) to develop an options paper on the longer term approach to assessing a radiation oncology facility’s conformance with the standards.
Qualitative KPI:Radiation oncology standards reduce adverse outcomes for patients.
2010-11 Reference Point:Trial of radiation oncology standards indicate that the standards are effective.
Result: Indicator met.
The outcomes of the trial indicate the standards represent good clinical practice, are not onerous and are a sound guide for the provision of safe, quality radiation oncology services. The standards are strongly supported by the sector.
Qualitative KPI:Radiation oncology initiatives are developed to increase workforce capacity to support capital expansions.
2010-11 Reference Point:Workforce research and capital projects are progressed in consultation with the radiation oncology sector to increase the capacity of the sector.
Result: Indicator met.
In 2010-11, the department continued to fund radiation therapy interns to undertake their national professional development program (intern year), radiation oncology medical physics registrar positions and clinical preceptor (tutors) positions for radiation therapy interns and radiation oncology medical physics registrars, to increase workforce capacity to support service delivery.

In consultation with the radiation oncology sector, the department developed, progressed and funded: cancer research projects with Cancer Australia through the Priority-driven Collaborative Cancer Research Scheme; the introduction of virtual environment radiotherapy training systems into radiation therapy teaching universities; a pilot national training network for radiation oncologists; and a symposium on lessons learned from previous oncology related capital works programs. The department continued to assess Radiation Oncology Health Program Grants in accordance with program guidelines and progressed the review of the program guidelines.
Top of page

Whole of Program Performance Information

Qualitative Deliverable:Produce relevant and timely evidence-based policy research.
2010-11 Reference Point:Relevant evidence-based policy research produced in a timely manner.
Result: Deliverable met.
Significant progress was made in collaboration with stakeholders and technical experts to improve service planning data. A range of reform initiatives that are expected to deliver improvements in quality standards and workforce capacity of radiation oncology services have also been informed by specialist technical advice from recognised leaders in the field who participate on the Radiation Oncology Reform Implementation Committee and its working groups.
Qualitative Deliverable:Stakeholders participate in program development through a range of avenues.
2010-11 Reference Point:Stakeholders participated in program development through avenues such as regular consultative committees, conferences, stakeholder engagement forums, surveys, submissions on departmental discussion papers and meetings.
Result: Deliverable met.
The Radiation Oncology Reform Implementation Committee continued to support and facilitate the planning and implementation of strategies to ensure improved radiotherapy service outcomes for patients. It met twice in 2010-11 and also provided quarterly reports to the Clinical, Technical and Ethical Principal Committee of the Australian Health Ministers’ Advisory Council. Each of the working groups met at least three times.
Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
2010-11 Target:0.5%2010-11 Actual:-0.7%
Result: Deliverable substantially met.
The variance can be attributed to less than predicted Radiation Oncology Health Program Grant expenditure, which is demand driven, and the inability of radiation oncology facilities to successfully recruit to the projected number of approved radiation therapy and radiation oncology medical physics training positions for which funding would have been provided.
Top of page

Program 3.6: Targeted Assistance - Medical

Program 3.6 aims to provide targeted assistance to eligible people to access health care, currently not covered under existing programs, including breast prostheses reimbursements.

Targeted Assistance

The Targeted Assistance Program provides assistance to eligible people for health and medical services not covered by existing programs such as Medicare.

During 2010-11, the department managed Reciprocal Health Care Agreements with 10 countries for reciprocal access to health services while Australian residents are visiting those countries and for residents of those countries while visiting Australia. This supports a safer environment for Australian residents travelling overseas for tourism or business purposes. A new Reciprocal Health Care Agreement with Slovenia was negotiated and came into operation on 1 July 2011. In 2010-11, a total of 38,547 visitors to Australia from reciprocal countries accessed 127,267 MBS services with total benefits paid of $7.3 million.

Through the six Disaster Health Care Assistance Schemes, the department pays out-of-pocket expenses for health care required by eligible victims of specific international disasters, and their families. The schemes cover incidents arising from acts of terrorism, such as the Bali bombings, civil disturbances, or natural disasters, such as the Asian Tsunami. Out-of-pocket costs are those expenses which are not covered by Medicare, other government programs (including those provided by states and territories) or private travel or health insurance. Under most schemes, assistance is provided for the lifetime of the client.
Qualitative Deliverable:Assistance provided to eligible people who have incurred an injury or ill health as a result of a specific international disaster.
2010-11 Reference Point:Appropriate assistance provided in a timely manner.
Result: Deliverable met.
In 2010-11, the department provided financial assistance to victims of specific international acts of terrorism or natural disasters. This assistance covered out-of-pocket expenses for health care delivered in Australia for ill health or injury. Six Disaster Health Care Assistance Schemes provide financial assistance to victims and their families as a result of the following incidents:
  • 2002 and 2005 Bali Bombings;
  • 2004 Asian Tsunami;
  • 2005 London Bombings;
  • 2006 Egypt Bombings; and
  • 2008 Mumbai Terrorist Attacks.
    Guidelines are in place to facilitate payments to eligible persons through Medicare Australia on the department’s behalf.
  • Quantitative Deliverable:Funds available for additional health care assistance to eligible people affected by specific international disasters.
    2010-11 Target:$780,0002010-11 Actual:$322,574
    Result: Deliverable met.
    The Disaster Health Care Assistance Schemes are demand driven programs. Eligible people receive reimbursement for all ‘out-of-pocket’ health care costs related to any injury or illness which has resulted from one of the incidents covered by the schemes. In 2010-11, Medicare Australia paid 2,910 claims on the department’s behalf.
    Quantitative Deliverable:Funds available for health care assistance to people under Reciprocal Health Care Agreements.
    2010-11 Target:$50,0002010-11 Actual:$0
    Result: Deliverable met.
    Whilst these funds were not spent, they relate to the Italian reciprocal agreement, which is the only agreement with a financial adjustment provision, set out in the agreement’s administrative arrangements. While the identification of costs to be reimbursed does not occur on a regular basis, funds must be available to meet this obligation on an annual basis.
    Top of page

    National External Breast Prostheses Reimbursement Program

    In 2010-11, an evaluation of the External Breast Prostheses Reimbursement Program was completed. The independent evaluation36 found the program easily accessible, efficient and sensitive to the needs of women accessing the service. Based on the evaluation findings, the department is working with Medicare Australia to increase community awareness of the program.
    Qualitative Deliverable:Reimbursement for breast prostheses provided to eligible women.
    2010-11 Reference Point:Appropriate assistance provided in a timely manner.
    Result: Deliverable met.
    An independent evaluation found the program was easily accessible, efficient and sensitive to the needs of women accessing the service.
    Quantitative KPI:Percentage of claims by eligible women under the National External Breast Prostheses Reimbursement Program processed within ten days of lodgement.
    2010-11 Target:90%2010-11 Actual:99%
    Result: Indicator met.
    During 2010-11, 14,910 reimbursements were processed under this program. Of the 13,483 eligible claims made, 13,443 were processed within ten days of lodgement.

    Whole of Program Performance Information

    Qualitative Deliverable:Produce relevant and timely evidence-based policy research.
    2010-11 Reference Point:Relevant evidence-based policy research produced in a timely manner.
    Result: Deliverable met.
    The department ensures all research is completed in a timely manner when considering or negotiating Health Care Agreements with other countries.
    Qualitative Deliverable:Stakeholders participate in program development through a range of avenues.
    2010-11 Reference Point:Stakeholders participated in program development through avenues such as regular consultative committees, conferences, stakeholder engagement forums, surveys, submissions on departmental discussion papers and meetings.
    Result: Deliverable met.
    The department consulted widely with professional, industry and consumer peak groups on a range of issues and through a variety of fora.
    Quantitative Deliverable:Percentage of variance between actual and budgeted expenses.
    2010-11 Target:0.5%2010-11 Actual:-15.8%
    Result: Deliverable not met.
    This is a demand driven program, meeting the needs of the public as required.
    Top of page

    Outcome 3 – Financial Resources Summary

    (A) Budget
    Estimate1
    2010-11
    $’000
    (B) Actual
    2010-11
    $’000
    Variation
    (Column B
    minus
    Column A)
    $’000
    Program 3.1: Medicare Services
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    1,997
    1,672
    (325)
      Special appropriations
      Dental Benefits Act 2008
    68,523
    57,509
    (11,014)
      Health Insurance Act 1973
    16,392,466
    16,266,209
    (126,257)
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    32,445
    32,579
    134
      Revenues from other sources (s31)
    1,423
    1,402
    (21)
      Unfunded depreciation expense
    741
    953
    212
      Operating loss / (surplus)
    -
    2
    2
    Total for Program 3.1
    16,497,595
    16,360,326
    (137,269)
    Program 3.2: Alternative Funding to Health Services Protection
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    6,643
    7,626
    983
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    522
    524
    2
      Revenues from other sources (s31)
    23
    23
    -
      Unfunded depreciation expense
    12
    15
    3
      Operating loss / (surplus)
    -
    -
    -
    Total for Program 3.2
    7,200
    8,188
    988
    Program 3.3: Diagnostic Imaging Services
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    5,550
    5,730
    180
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    2,241
    2,250
    9
      Revenues from other sources (s31)
    98
    97
    (1)
      Unfunded depreciation expense
    51
    66
    15
      Operating loss / (surplus)
    -
    -
    -
    Total for Program 3.3
    7,940
    8,143
    203
    Program 3.4: Pathology Services
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    4,700
    4,207
    (493)
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    2,631
    2,642
    11
      Revenues from other sources (s31)
    115
    114
    (1)
      Unfunded depreciation expense
    60
    77
    17
      Operating loss / (surplus)
    -
    -
    -
    Total for Program 3.4
    7,506
    7,040
    (466)
    Program 3.5: Chronic Disease - Radiation Oncology
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    80,669
    80,091
    (578)
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    2,529
    2,540
    11
      Revenues from other sources (s31)
    111
    109
    (2)
      Unfunded depreciation expense
    58
    74
    16
      Operating loss / (surplus)
    -
    -
    -
    Total for Program 3.5
    83,367
    82,814
    (553)
    Program 3.6: Targeted Assistance - Medical
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    6,808
    5,731
    (1,077)
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    1,150
    1,154
    4
      Revenues from other sources (s31)
    50
    50
    -
      Unfunded depreciation expense
    26
    34
    8
      Operating loss / (surplus)
    -
    -
    -
    Total for Program 3.6
    8,034
    6,969
    (1,065)
    Outcome 3 Totals by appropriation type
    Administered Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    106,367
    105,057
    (1,310)
      Special appropriations
    16,460,989
    16,323,718
    (137,271)
    Departmental Expenses
      Ordinary Annual Services (Annual Appropriation Bill 1)
    41,518
    41,689
    171
      Revenues from other sources (s31)
    1,820
    1,795
    (25)
      Unfunded depreciation expense
    948
    1,219
    271
      Operating loss / (surplus)
    -
    2
    2
    Total expenses for Outcome 3
    16,611,642
    16,473,480
    (138,162)
    Average Staffing Level (Number)
    273
    265
    (8)

    1 Budgeted appropriations taken from the 2011-12 Health and Ageing Portfolio Budget Statements and re-aligned to the 2010-11 outcome structure.

    Top of page



    36 Available at: www.health.gov.au/internet/main/publishing.nsf/content/cancer-pubs-evprosth


    Help with accessing large documents

    When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:

    1. Click the link with the RIGHT mouse button
    2. Choose "Save Target As.../Save Link As..." depending on your browser
    3. Select an appropriate folder on a local drive to place the downloaded file

    Attempting to open large documents within the browser window (by left-clicking) may inhibit your ability to continue browsing while the document is opening and/or lead to system problems.

    Help with accessing PDF documents

    To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.


    prev page | TOC | next page


    Produced by the Portfolio Strategies Division, Australian Government Department of Health and Ageing.
    URL: http://www.health.gov.au/internet/annrpt/publishing.nsf/Content/annual-report-1011-toc~1011part2~1011part2.4~1011outcome3
    If you would like to know more or give us your comments contact: annrep@health.gov.au